Actemra 200mg, a drug known scientifically as tocilizumab, is a a potent biologic agent primarily employed for the control of rheumatoid arthritis. This remarkable agent operates by blocking the activity of interleukin-6 (IL-6), a communication protein essential in the inflammatory process. Moreover, Actemra has shown promise in the management of